Showing results (421-430 of 440) with videos related to
Sort By:
Pageof 44
Nature Medicine|April 29, 2020
Locoregional delivery of CAR T cells to the cerebrospinal fluid for treatment of metastatic medulloblastoma and ependymomaLaura K Donovan, Alberto Delaidelli, Sujith K Joseph, et al.Nature Communications|September 27, 2019
Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomasAna S Guerreiro Stucklin, Scott Ryall, Kohei Fukuoka, et al.Acta Neuropathologica|July 19, 2018
Heterogeneity within the PF-EPN-B ependymoma subgroupFlorence M G Cavalli, Jens-Martin Hübner, Tanvi Sharma, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2021
Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed MedulloblastomaRahul Kumar, Kyle S Smith, Maximilian Deng, et al.Cell Reports. Medicine|August 4, 2020
Pattern of Relapse and Treatment Response in WNT-Activated MedulloblastomaLiana Nobre, Michal Zapotocky, Sara Khan, et al.Nature Medicine|April 12, 2022
Stratification of radiosensitive brain metastases based on an actionable S100A9/RAGE resistance mechanismCátia Monteiro, Lauritz Miarka, María Perea-García, et al.Nature|October 31, 2019
Recurrent noncoding U1 snRNA mutations drive cryptic splicing in SHH medulloblastomaHiromichi Suzuki, Sachin A Kumar, Shimin Shuai, et al.The Lancet. Oncology|April 18, 2015
Molecular subgroups of atypical teratoid rhabdoid tumours in children: an integrated genomic and clinicopathological analysisJonathon Torchia, Daniel Picard, Lucie Lafay-Cousin, et al.Acta Neuropathologica|November 1, 2013
TERT promoter mutations are highly recurrent in SHH subgroup medulloblastomaMarc Remke, Vijay Ramaswamy, John Peacock, et al.Nature|February 21, 2014
Epigenomic alterations define lethal CIMP-positive ependymomas of infancyS C Mack, H Witt, R M Piro, et al.Pageof 44